Literature DB >> 2846543

Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli.

S Shuman1, M Golder, B Moss.   

Abstract

The putative structural gene encoding the vaccinia virus type I DNA topoisomerase (EC 5.99.1.2) was expressed in Escherichia coli under the control of a bacteriophage T7 promoter. Provision of T7 RNA polymerase resulted in the accumulation to high level of a Mr = 33,000 type I topoisomerase with the properties of the vaccinia enzyme. A simple purification scheme yielded approximately 8 mg of recombinant vaccinia topoisomerase from 400 ml of bacteria. DNA unwinding by the enzyme was stimulated by magnesium, manganese, calcium, cobalt, and spermidine, but inhibited by copper and zinc. Like eukaryotic cellular type I topoisomerases, but unlike the prokaryotic counterpart, the recombinant topoisomerase relaxed positively and negatively supercoiled DNA. The viral topoisomerase I was, however, resistant to the effects of camptothecin, a drug that specifically inhibits cellular type I topoisomerases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846543

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  DNA strand transfer catalyzed by vaccinia topoisomerase: ligation of DNAs containing a 3' mononucleotide overhang.

Authors:  C Cheng; S Shuman
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

2.  Recombinogenic flap ligation pathway for intrinsic repair of topoisomerase IB-induced double-strand breaks.

Authors:  C Cheng; S Shuman
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3'-para-nitrophenyl phosphate ester.

Authors:  G Woodfield; C Cheng; S Shuman; A B Burgin
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

4.  Mutational analysis of vaccinia virus topoisomerase identifies residues involved in DNA binding.

Authors:  J Sekiguchi; S Shuman
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

5.  Conditional growth of Escherichia coli caused by expression of vaccinia virus DNA topoisomerase I.

Authors:  M E Fernandez-Beros; Y C Tse-Dinh
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

6.  Purification and characterization of UL9, the herpes simplex virus type 1 origin-binding protein.

Authors:  D S Fierer; M D Challberg
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Characterization of mimivirus DNA topoisomerase IB suggests horizontal gene transfer between eukaryal viruses and bacteria.

Authors:  Delphine Benarroch; Jean-Michel Claverie; Didier Raoult; Stewart Shuman
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Mapping the active-site tyrosine of vaccinia virus DNA topoisomerase I.

Authors:  S Shuman; E M Kane; S G Morham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

10.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.

Authors:  H Tamura; C Kohchi; R Yamada; T Ikeda; O Koiwai; E Patterson; J D Keene; K Okada; E Kjeldsen; K Nishikawa
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.